Oslo, 2 December 2021, Carlos de Sousa, Chief Executive Officer and primary
insider in Ultimovacs ASA, has today bought 1,000 shares in the company at a
price of NOK 107.60 per share. Following this transaction, Carlos de Sousa and
closely related parties hold 15,056 shares and 416,035 share options in
Ultimovacs ASA.

This information is subject to the disclosure requirements pursuant to the
Market Abuse Regulation article 19 and section 5-12 of the Norwegian Securities
Trading Act.